Darr, MD ‘s research article “Non-homologous use of adipose-derived cell and tissue therapies: Osteoarthritis as a case study” has been published.
Adipose tissue is widely recognized as an abundant and accessible human tissue that serves as a source of cells and extracellular matrix scaffolds for regenerative surgical applications. Increasingly, orthopedic surgeons are turning to adipose tissue as a resource in their treatment of osteoarthritis and related conditions. In the U.S., the regulatory landscape governing the orthopedic surgical utilization of autologous and allogeneic adipose tissue remains complex. This manuscript reviews the Food and Drug Administration's nomenclature and guidance regarding adipose tissue products. Additionally, it surveys recent pre-clinical and clinical trial literature relating to the application of adipose-derived cells and tissues in the treatment of osteoarthritis.
Dr. Darr is available for in person interview or Zoom session to discuss the many advances in Regenerative Medicine. His background as an Orthopedic surgeon gives him a unique perspective of Regenerative therapies.
For more information on the treatment options, please visit www.drkevindarr.com
Dr. Darr is a native New Orleanian with offices in both Covington and Metairie. He attended LSU Medical School with a fellowship at New England Baptist Hospital in Boston, MA where he was associated with the Boston Celtics. Dr. Darr is board certified in Orthopedic Surgery, Sports Medicine and Regenerative Medicine. Dr. Darr has completed over 1,500 regenerative procedures and has conducted 10 IRB approved studies on its efficacy. Dr. Darr prides himself on determining what regenerative procedures are the most evidence based and provides a uniquely designed treatment plan to each patient.
Dr. Kevin Darr is a respected Lecturer on Orthopedics and Regenerative Therapies. During the pandemic, Dr. Darr was able to have his research published in Regenerative Medicine an internationally viewed journal. On June 12, 2020 Dr. Darr presented his findings on “Effective Clinical Modulation of Knee Osteoarthritis Symptoms through Combined Cellular Therapy (Lipoaspirate, BMC and PRP)” at The OrthoBiologic Institute (TOBI) annual meeting.
To learn more about Dr. Darr’s publication, click here https://www.futuremedicine.com/doi/10.2217/rme-2020-0069